1、 XRF SCIENTIFIC LIMITED ABN 80 107 908 314 ANNUAL FINANCIAL REPORT FOR THE YEAR ENDED 30 JUNE 2019 XRF SCIENTIFIC LIMITED|2019 ANNUAL REPORT 1 CONTENTS CHAIRMANS LETTER 3 DIRECTORS REPORT 4 AUDITORS INDEPENDENCE DECLARATION 17 CONSOLIDATED STATEMENT OF PROFIT 18 OR LOSS AND OTHER COMPREHENSIVE INCOM
2、E CONSOLIDATED STATEMENT OF 19 FINANCIAL POSITION CONSOLIDATED STATEMENT OF 20 CHANGES IN EQUITY CONSOLIDATED STATEMENT OF 21 CASH FLOWS NOTES TO THE CONSOLIDATED 22 FINANCIAL STATEMENTS DIRECTORS DECLARATION 53 AUDITORS REPORT 54 SHAREHOLDER INFORMATION 58 CORPORATE DIRECTORY 60FINANCIAL RESULTS SU
3、MMARY 2 XRF SCIENTIFIC LIMITED|2019 ANNUAL REPORT Sales up 20%Net Profit After Tax up 109%Operating Cash Flow up 380%Earnings Per Share up 100%21,05021,50824,24829,021FY16FY17FY18FY19Sales Revenue($000)1,5377941,0242,138FY16FY17FY18FY19Net Profit After Tax($000)4251568083,876FY16FY17FY18FY19Operatin
4、g Cash Flow($000)1.20.60.81.6FY16FY17FY18FY19Earnings Per Share(Cents)XRF SCIENTIFIC LIMITED|2019 ANNUAL REPORT 3 CHAIRMANS LETTER Dear Fellow XRF Shareholder,After some challenging years XRFs financial performance has improved significantly with all major businesses strengthening their operations,i
5、mproving market share and generating better returns for our shareholders.Our substantial capital investment programme and a strong focus on management and consolidation of our laboratory services business in both Australia and overseas is beginning to generate the previously planned benefits which a
6、re expected to grow in the years ahead.Our Consumables business has successfully consolidated and expanded its product range and is winning new business around the world due to its high product quality and excellent customer service.Despite current trade tensions this business is well placed to reta